Nurotron Biotechnology

company

About

Hangzhou Nurotron Biotechnology is a high-tech enterprise providing nerve electronic products.

  • 11 - 50

Details

Last Funding Type
Series E
Last Funding Money Raised
$24M
Industries
Biotechnology,Electronics,Enterprise,Health Care
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Hangzhou Nurotron Biotechnology Co., Ltd., (诺尔康神经电子科技) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$24M
Nurotron Biotechnology has raised a total of $24M in funding over 2 rounds. Their latest funding was raised on Oct 9, 2020 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 9, 2020 Series E $24M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Nurotron Biotechnology is funded by 1 investors. Superstring Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Superstring Capital Series E